Park National Corp OH decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,613 shares of the company's stock after selling 791 shares during the quarter. Park National Corp OH's holdings in HCA Healthcare were worth $10,962,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its position in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after buying an additional 587,036 shares during the last quarter. GAMMA Investing LLC lifted its position in HCA Healthcare by 40,527.3% in the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after buying an additional 1,699,713 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in HCA Healthcare by 12.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,675,460 shares of the company's stock worth $502,889,000 after buying an additional 188,093 shares during the last quarter. Finally, Nuveen LLC bought a new stake in HCA Healthcare in the 1st quarter worth approximately $569,217,000. Institutional investors own 62.73% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on HCA shares. Morgan Stanley lowered their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. JPMorgan Chase & Co. boosted their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Barclays decreased their target price on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, July 28th. Finally, Truist Financial upped their target price on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $403.17.
View Our Latest Research Report on HCA Healthcare
Insider Transactions at HCA Healthcare
In related news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.
HCA Healthcare Stock Down 0.8%
HCA stock traded down $3.38 during midday trading on Tuesday, hitting $399.79. The stock had a trading volume of 1,319,771 shares, compared to its average volume of 1,098,924. The firm has a market cap of $93.55 billion, a price-to-earnings ratio of 16.42, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. The business has a 50-day moving average of $383.38 and a two-hundred day moving average of $364.05. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's payout ratio is presently 12.11%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report